Abstract:Excessive infiltration of activated neutrophils is regarded as a predominant cause of tissue injury in neutrophilic inflammation. Although programmed cell death like apoptosis maintains the homeostasis of activated neutrophils, this process is disrupted by an abnormal inflammatory response. Unlike endogenous calreticulin exposed during apoptosis, exogenous calreticulin acts as an "aged" signal and initiates premature macrophage-mediated programmed cell removal (PrCR), which is independent of...

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that in neutrophilic inflammation, excessive infiltration of activated neutrophils leads to tissue damage. Although programmed cell death such as apoptosis can maintain the homeostasis of activated neutrophils, abnormal inflammatory responses can disrupt this process. Therefore, the paper proposes a new strategy. By using nanotechnology to simulate exogenous "aging" signals, it stimulates macrophage - mediated programmed cell removal (PrCR) to specifically remove activated neutrophils and reduce inflammation and tissue damage. Specifically, the paper has developed a polymer nanoparticle named PC@PLGA. This nanoparticle consists of a polylactic - co - glycolic acid (PLGA) core and a hybrid membrane. This hybrid membrane is derived from platelet - derived extracellular vesicles (PEVs) and cell membranes expressing calreticulin (CRT) after treatment with doxorubicin. P - selectin in PEVs helps PC@PLGA to anchor activated neutrophils, and calreticulin simulates the exogenous "aging" signal secreted by macrophages to trigger PrCR. The research results show that PC@PLGA can specifically target activated neutrophils and mislead macrophages to recognize these cells as "aging" neutrophils, thereby initiating premature PrCR and preventing pro - inflammatory responses and tissue damage. In mouse models of acute lung injury (ALI) and severe acute pancreatitis (SAP), PC@PLGA significantly reduces the number of activated neutrophils, decreases the levels of inflammatory cytokines, and alleviates tissue damage. These findings indicate that specific removal of activated neutrophils through exogenous "aging" signals is an effective inflammatory treatment strategy.

Aged-Signal-Eliciting Nanoparticles Stimulated Macrophage-Mediated Programmed Removal of Inflammatory Neutrophils

Programmed cell clearance: Molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation

Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation

Inhibition of Non-Muscular Myosin Light Chain Kinase Accelerates the Clearance of Inflammatory Cells by Promoting the Lysosome-Mediated Cell Death

Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy

Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis.

In situ neutrophil apoptosis and macrophage efferocytosis mediated by Glycyrrhiza protein nanoparticles for acute inflammation therapy

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Neutrophil CD16b Crosslinking Induces Lipid Raft-Mediated Activation of SHP-2 and Affects Cytokine Expression and Retarded Neutrophil Apoptosis

Macrophage phagocytosis of wound neutrophils

Apoptotic Cells and Innate Immune Stimuli Combine to Regulate Macrophage Cytokine Secretion

Activating Macrophage Continual Efferocytosis via Microenvironment Biomimetic Short Fibers for Reversing Inflammation in Bone Repair

Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo.

Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death

Programmed Necrosis and Disease:We Interrupt Your Regular Programming to Bring You Necroinflammation

Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro‐inflammatory and anti‐inflammatory agents: key role for TNF‐α

Programmed necrosis in the cross talk of cell death and inflammation.

Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis

Anti-Inflammatory Neutrophils Reprogram Macrophages toward a Pro-Healing Phenotype with Increased Efferocytosis Capacity

NLRC4 Deficiency Leads to Enhanced Phosphorylation of MLKL and Necroptosis

Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury